JP2016047843A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016047843A5 JP2016047843A5 JP2015239450A JP2015239450A JP2016047843A5 JP 2016047843 A5 JP2016047843 A5 JP 2016047843A5 JP 2015239450 A JP2015239450 A JP 2015239450A JP 2015239450 A JP2015239450 A JP 2015239450A JP 2016047843 A5 JP2016047843 A5 JP 2016047843A5
- Authority
- JP
- Japan
- Prior art keywords
- specific binding
- binding member
- human
- member according
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009870 specific binding Effects 0.000 claims 25
- 101001076430 Homo sapiens Interleukin-13 Proteins 0.000 claims 11
- 102000019207 human interleukin-13 Human genes 0.000 claims 11
- 210000004602 germ cell Anatomy 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
- 102000003816 Interleukin-13 Human genes 0.000 claims 2
- 108090000176 Interleukin-13 Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 2
- 210000004899 c-terminal region Anatomy 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 230000027455 binding Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000009240 nasopharyngitis Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48751203P | 2003-07-15 | 2003-07-15 | |
| US60/487,512 | 2003-07-15 | ||
| US55821604P | 2004-03-31 | 2004-03-31 | |
| GB0407315.1 | 2004-03-31 | ||
| US60/558,216 | 2004-03-31 | ||
| GBGB0407315.1A GB0407315D0 (en) | 2003-07-15 | 2004-03-31 | Human antibody molecules |
| US57379104P | 2004-05-24 | 2004-05-24 | |
| US60/573,791 | 2004-05-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014020292A Division JP5922686B2 (ja) | 2003-07-15 | 2014-02-05 | Ｉｌ−１３に対するヒト抗体分子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016047843A JP2016047843A (ja) | 2016-04-07 |
| JP2016047843A5 true JP2016047843A5 (enExample) | 2016-08-12 |
Family
ID=44535047
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011085689A Expired - Lifetime JP5519567B2 (ja) | 2003-07-15 | 2011-04-07 | Ｉｌ−１３に対するヒト抗体分子 |
| JP2014020292A Expired - Lifetime JP5922686B2 (ja) | 2003-07-15 | 2014-02-05 | Ｉｌ−１３に対するヒト抗体分子 |
| JP2015239450A Pending JP2016047843A (ja) | 2003-07-15 | 2015-12-08 | Ｉｌ−１３に対するヒト抗体分子 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011085689A Expired - Lifetime JP5519567B2 (ja) | 2003-07-15 | 2011-04-07 | Ｉｌ−１３に対するヒト抗体分子 |
| JP2014020292A Expired - Lifetime JP5922686B2 (ja) | 2003-07-15 | 2014-02-05 | Ｉｌ−１３に対するヒト抗体分子 |
Country Status (8)
| Country | Link |
|---|---|
| JP (3) | JP5519567B2 (enExample) |
| KR (1) | KR101073590B1 (enExample) |
| AU (1) | AU2011200308B2 (enExample) |
| CY (1) | CY1111467T1 (enExample) |
| HK (1) | HK1216427A1 (enExample) |
| MX (1) | MXPA06000258A (enExample) |
| NO (2) | NO338853B1 (enExample) |
| RU (1) | RU2009148270A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201609980TA (en) * | 2014-06-18 | 2016-12-29 | Medimmune Llc | Cell culture methods and media comprising n-acetylcysteine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994004680A1 (en) * | 1992-08-21 | 1994-03-03 | Schering Corporation | Human interleukin-13 |
| CA2464695A1 (en) * | 2001-10-26 | 2003-05-01 | Centocor, Inc. | Il-13 mutein proteins, antibodies, compositions, methods and uses |
| ES2384100T3 (es) * | 2001-12-03 | 2012-06-29 | Alexion Pharmaceuticals, Inc. | Método para producir anticuerpos híbridos |
| AU2003223497A1 (en) * | 2002-04-05 | 2003-10-27 | Centocor, Inc. | Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| JP2006503018A (ja) * | 2002-08-30 | 2006-01-26 | グラクソ グループ リミテッド | ワクチン |
| GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| TWI307630B (en) * | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
-
2004
- 2004-07-15 KR KR1020067000933A patent/KR101073590B1/ko not_active Expired - Lifetime
- 2004-07-15 MX MXPA06000258A patent/MXPA06000258A/es active IP Right Grant
-
2006
- 2006-02-15 NO NO20060730A patent/NO338853B1/no unknown
-
2009
- 2009-12-24 RU RU2009148270/10A patent/RU2009148270A/ru not_active Application Discontinuation
-
2011
- 2011-01-25 AU AU2011200308A patent/AU2011200308B2/en not_active Expired
- 2011-04-07 JP JP2011085689A patent/JP5519567B2/ja not_active Expired - Lifetime
- 2011-05-16 CY CY20111100456T patent/CY1111467T1/el unknown
-
2014
- 2014-02-05 JP JP2014020292A patent/JP5922686B2/ja not_active Expired - Lifetime
-
2015
- 2015-12-08 JP JP2015239450A patent/JP2016047843A/ja active Pending
-
2016
- 2016-04-19 HK HK16104446.4A patent/HK1216427A1/zh unknown
- 2016-04-27 NO NO20160707A patent/NO342727B1/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2495050C2 (ru) | Связующий элемент для рецептора gm-csf | |
| HRP20191342T1 (hr) | Anti-phf-tau antitijela i njihove upotrebe | |
| JP2013121353A5 (enExample) | ||
| JP2017052784A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| JP2018521691A5 (enExample) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| JP2011527902A5 (enExample) | ||
| RU2018106364A (ru) | Антитела против рецептора tfr и их применение при лечении пролиферативных и воспалительных расстройств | |
| HRP20150623T1 (hr) | Monoklonalno protutijelo sposobno za vezivanje na specifiäśni diskontinuirani epitop koji se pojavljuje u podruäśju ad1 od humanog glikoproteina citomegalovirusa gb, te njegov fragment koji se veže na antigen | |
| JP2014503189A5 (enExample) | ||
| JP2021501744A5 (enExample) | ||
| HRP20192098T1 (hr) | Antitijela na glukokortikoidom inducirani receptor faktora nekroze tumora (gitr) i njihove primjene | |
| JP2016519124A5 (enExample) | ||
| JP2016520595A5 (enExample) | ||
| JP2011527899A5 (enExample) | ||
| JP2012254092A5 (enExample) | ||
| HRP20241528T1 (hr) | Monoklonsko protutijelo protiv interleukina-31 | |
| HRP20170254T1 (hr) | Humanizirana i kimerna monoklonska protutijela usmjerena na cd47 | |
| JP2018519364A5 (enExample) | ||
| JP2012500020A5 (enExample) | ||
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| JP2013198490A5 (enExample) | ||
| HRP20240774T1 (hr) | Anti-il-33 antitijela i njihove upotrebe | |
| JP2015533795A5 (enExample) |